Nabriva Therapeutics (NBRVF) Q1 2017 Earnings

9MayExpected
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-141.34
-94.42
-47.49
-0.57

Details

Expected EPS
-0.6
Actual EPS
-5.6
Surprise EPS
-5
Surprise Percent
+833.33%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -5.6 per share for Q1 2017.

0 Comments

Share your thoughts